The use of a synthetic compound modeled after tetrahydrocannabinol (THC), marijuana’s main psychoactive ingredient, has proven to be effective and well tolerated in treating chronic…
The U.S. Food and Drug Administration has approved the use of the first opioid painkiller for the treatment of neuropathic pain caused by diabetic peripheral…